alexa

GET THE APP

Tracheobronchial Aspergillosis|OMICS International|Clinical Trials

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Tracheobronchial Aspergillosis

Tracheobronchial aspergillosis mainly involves the trachea, primary bronchus and segmental bronchus. The main symptoms including dyspnea, asthma and cough. Bronchoscopic findings supply the main evidence for diagnosis. Voriconazole has been widely used as azole antifungal agent in recent years, which is also a first-line drug in the treatment of invasive pulmonary aspergillosis (IPA), but rare report exists in the treatment of tracheobronchial aspergillosis. Two patients have been remitted with Voriconazole in this study, and it was found that Voriconazole could improve therapeutic effect and shorten therapeutic time with less adverse effects
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on January, 2021

Top